Take a look at COA on ventureThis company is really new in the market - very impressive revenue growth - however margins are weak. The upside is that J&J has cut them a 40% rebate on the sale of Accuvue lenses....which currently is approx. about 45% of their revenues...that should help profits. Pretty cheap at these growth rates.....have a look at CTAC on nasdaq for an idea of where revenues can go....